Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
KELOWNA, BC / ACCESSWIRE / April 12, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infused...
Adastra Labs Receives Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Dealer’s License
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESLANGLEY, BC / ACCESSWIRE / February 22, 2023 / Adastra Holdings...
Cube Psytech Signs Letter of Intent to Acquire Translational Life Sciences and Announces Private Placement
VANCOUVER, BC / ACCESSWIRE / February 10, 2023 / Cube Psytech Holdings Inc. (the "Company" or "CUBE"), a biopharmaceutical and biotechnology company focused on the...
Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and Other Drug Developers
VANCOUVER, BC / ACCESSWIRE / January 13, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN: A3CSSU) (the "Company" or "Core One"), is pleased to announce that...
Ketamine Media Scheduled to Launch North America’s Largest Psilocybin Awareness Network
Ketamine Media announced today that it is in the final stages of launching its digital ecosystem of premium online properties to raise awareness about the...